Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TLDC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TMEM19 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | DKK4 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | ANTXRL | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | LY6L | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | ITGA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SMYD4 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | GSTK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | FNTB | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
mRNA | TSNAX | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |